<http://purl.obolibrary.org/obo/CHEBI_50906>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "chemical role" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/0.22563318099837548> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5638302" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-09-18" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/1142944137> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/1142944138>
] .

<http://model.geneontology.org/0.7874502024979698>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5638302" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-09-18" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:3477813" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://model.geneontology.org/1142944133>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Ligand-responsive EGFR cancer variants harbor mutations in the kinase domain or point mutations in the extracellular domain. These altered EGFR proteins are able to signal in the absence of ligands, but their ligand binding ability is preserved and downstream signaling is potentiated when ligand is available (Greulich et al. 2005, Lee et al. 2006)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Signaling by Ligand-Responsive EGFR Variants in Cancer" ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5638302" , "Reviewed: Savas, S, 2011-11-15" , "Edited: Matthews, L, 2011-11-07" , "Reviewed: Greulich, H, 2011-11-15" , "Edited: Wu, G, 2011-11-07" , "Edited: Gillespie, ME, 2011-11-07" , "Edited: Haw, R, 2011-11-07" , "Edited: D'Eustachio, P, 2011-11-07" , "Authored: Orlic-Milacic, M, 2011-11-04" , "Edited: Jassal, B, 2011-11-07" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-09-18" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/BFO_0000051>
        a       <http://www.w3.org/2002/07/owl#ObjectProperty> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has part" .

<http://purl.obolibrary.org/obo/RO_0002327>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "enables" .

<http://purl.org/pav/providedBy>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://model.geneontology.org/0.22563318099837548>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://purl.obolibrary.org/obo/ECO_0000313> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5638302" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-09-18" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:3477813" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/CHEBI_36080>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "chebi protein" .

<http://purl.obolibrary.org/obo/RO_0002406>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly activates (process to process)" .

<http://model.geneontology.org/1142944138>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Recombinant monoclonal antibody Cetuximab acts as an antagonist of EGFR ligand binding, and is approved for the treatment of tumors that over-express wild-type EGFR receptor (Cunningham et al. 2004, Li et al. 2005, Burtness et al. 2005). Effective concentrations of covalent tyrosine kinase inhibitors (TKIs) inhibit wild-type EGFR, causing severe side effects (Zhou et al. 2009). Hence, covalent TKIs have not shown much promise in clinical trials (Reviewed by Pao and Chmielecki in 2010)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Inhibition of Signaling by Overexpressed EGFR" ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Reviewed: Savas, S, 2011-11-15" , "Reviewed: Greulich, H, 2011-11-15" , "Edited: Jassal, B, 2011-11-07" , "Edited: Gillespie, ME, 2011-11-07" , "https://reactome.org/content/detail/R-HSA-5638302" , "Edited: Wu, G, 2011-11-07" , "Edited: Haw, R, 2011-11-07" , "Edited: D'Eustachio, P, 2011-11-07" , "Authored: Orlic-Milacic, M, 2011-11-04" , "Edited: Matthews, L, 2011-11-07" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-09-18" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/BFO_0000002>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Continuant" .

<http://purl.obolibrary.org/obo/GO_0008150>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Biological Process" .

<http://purl.obolibrary.org/obo/RO_0002334>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "regulated by" .

<http://purl.obolibrary.org/obo/BFO_0000015>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Process" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/0.7874502024979698> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5638302" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-09-18" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000050> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/1142944137> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/1142943460>
] .

<http://model.geneontology.org/1142943460>
        a       <http://purl.obolibrary.org/obo/GO_0008150> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "The pathway \"Signaling by EGFR in Cancer\" shows signaling by constitutively active EGFR cancer variants in the context of \"Signaling by EGFR\", allowing users to compare cancer events with the wild-type EGFR events. Red lines emphasize cancer related events and physical entities, while wild-type entities and events are shaded. Please refer to \"Signaling by Ligand-Responsive EGFR Variants in Cancer\", \"Signaling by EGFRvIII in Cancer\" and \"Signaling by Overexpressed Wild-Type EGFR in Cancer\" for detailed pathway summations." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Signaling by EGFR in Cancer" ;
        <http://purl.obolibrary.org/obo/BFO_0000051>
                <http://model.geneontology.org/1142944133> , <http://model.geneontology.org/1142944135> , <http://model.geneontology.org/1142944137> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5638302" , "Reviewed: Greulich, H, 2011-11-15" , "Edited: D'Eustachio, P, 2011-11-07" , "Edited: Haw, R, 2011-11-07" , "Edited: Matthews, L, 2011-11-07" , "Reviewed: Savas, S, 2011-11-15" , "Edited: Jassal, B, 2011-11-07" , "Edited: Gillespie, ME, 2011-11-07" , "Authored: Orlic-Milacic, M, 2011-11-04" , "Edited: Wu, G, 2011-11-07" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-09-18" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002234>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has output" .

<http://purl.obolibrary.org/obo/RO_0002413>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly provides input for (process to process)" .

<http://purl.obolibrary.org/obo/CHEBI_24431>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "chemical entity" .

<http://purl.obolibrary.org/obo/BFO_0000050>
        a       <http://www.w3.org/2002/07/owl#ObjectProperty> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "part of" .

<http://purl.obolibrary.org/obo/GO_0032991>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "protein-containing complex" .

<http://purl.org/dc/elements/1.1/source>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://model.geneontology.org/1142944137>
        a       <http://purl.obolibrary.org/obo/GO_0008150> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Signaling by EGFR is frequently activated in cancer through genomic amplification of the EGFR locus, resulting in over-expression of the wild-type protein (Wong et al. 1987)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Signaling by Overexpressed Wild-Type EGFR in Cancer" ;
        <http://purl.obolibrary.org/obo/BFO_0000050>
                <http://model.geneontology.org/1142943460> ;
        <http://purl.obolibrary.org/obo/BFO_0000051>
                <http://model.geneontology.org/1142944138> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Reviewed: Savas, S, 2011-11-15" , "Reviewed: Greulich, H, 2011-11-15" , "Edited: Gillespie, ME, 2011-11-07" , "https://reactome.org/content/detail/R-HSA-5638302" , "Edited: Haw, R, 2011-11-07" , "Edited: Jassal, B, 2011-11-07" , "Edited: Wu, G, 2011-11-07" , "Edited: Matthews, L, 2011-11-07" , "Edited: D'Eustachio, P, 2011-11-07" , "Authored: Orlic-Milacic, M, 2011-11-04" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-09-18" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002333>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "enabled by" .

<http://purl.obolibrary.org/obo/RO_0002305>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "causally upstream of with a negative effect" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5638302" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-09-18" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/1142943460> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/1142944137>
] .

<http://purl.obolibrary.org/obo/RO_0002233>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has input" .

<http://purl.obolibrary.org/obo/RO_0002304>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "causally upstream of with a positive effect" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5638302" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-09-18" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/1142943460> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/1142944135>
] .

<http://purl.obolibrary.org/obo/RO_0002411>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "causally upstream of" .

<http://purl.obolibrary.org/obo/GO_0005575>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Cellular Component" .

<http://geneontology.org/lego/evidence>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/RO_0002629>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly positively regulates" .

<http://purl.org/dc/elements/1.1/date>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://geneontology.org/lego/modelstate>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/CHEBI_33695>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "chebi gene" .

<http://purl.obolibrary.org/obo/ECO_0000313>
        a       <http://www.w3.org/2002/07/owl#Class> .

<http://purl.obolibrary.org/obo/RO_0001025>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "located in" .

<http://model.geneontology.org/721961662>
        a       <http://www.w3.org/2002/07/owl#Ontology> ;
        <http://geneontology.org/lego/modelstate>
                "development" ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5638302" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-09-18" ;
        <http://purl.org/dc/elements/1.1/title>
                "Reactome:unexpanded:Signaling by Overexpressed Wild-Type EGFR in Cancer" .

<http://purl.obolibrary.org/obo/GO_0003674>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Molecular Function" .

<http://model.geneontology.org/1142944135>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "EGFRvIII (EGFR V30_R297delinsG) is the most prevalent EGFR variant in glioblastoma, but it is also found in other cancer types. In-frame deletion of the ligand binding domain in EGFRvIII is frequently accompanied with genomic amplification, resulting in over-expression of EGFRvIII. EGFRvIII dimerizes and autophosphorylates spontaneously and is therefore constitutively active (Fernandes et al. 2001)" ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Signaling by EGFRvIII in Cancer" ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: Orlic-Milacic, M, 2011-11-04" , "Reviewed: Greulich, H, 2011-11-15" , "Reviewed: Savas, S, 2011-11-15" , "Edited: Gillespie, ME, 2011-11-07" , "https://reactome.org/content/detail/R-HSA-5638302" , "Edited: Haw, R, 2011-11-07" , "Edited: Jassal, B, 2011-11-07" , "Edited: D'Eustachio, P, 2011-11-07" , "Edited: Wu, G, 2011-11-07" , "Edited: Matthews, L, 2011-11-07" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-09-18" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/RO_0002429>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "involved in positive regulation_of" .

<http://purl.obolibrary.org/obo/RO_0000087>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has role" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5638302" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-09-18" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://model.geneontology.org/1142943460> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://model.geneontology.org/1142944133>
] .

<http://purl.obolibrary.org/obo/RO_0002024>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly positively regulated by" .

<http://purl.obolibrary.org/obo/BFO_0000066>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "occurs in" .

<http://purl.obolibrary.org/obo/RO_0002630>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly negatively regulates" .

<http://purl.org/dc/elements/1.1/contributor>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/RO_0002408>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly inhibits (process to process)" .

<http://purl.obolibrary.org/obo/RO_0002430>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "involved in negative regulation_of" .

<http://purl.org/dc/elements/1.1/title>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/RO_0002428>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "involved in regulation of" .

<http://purl.obolibrary.org/obo/RO_0002023>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly negatively regulated by" .
